Formulation and Evaluation of Moxifloxacin Hydrochloride Loaded Cubosomal Gel for Ocular Delivery
Abstract
This study aimed to develop and evaluate an ocular, prolonged-release cubogel formulation of moxifloxacin hydrochloride (MX) to treat conjunctivitis. Using glycerol monooleate and poloxamer 407 in varying concentrations, a cubosome containing the antibiotic MX was developed using a top-down approach. Further, by dispersing optimized cubosomes in a cold in-situ gelling system, MX cubogels were prepared. Following Higuchi's release kinetic model, formulations MA4, MA8, MA11, and MA14 released 95.84, 95.77, 97.45, and 97.68% of MX after 12 hours. The in-vitro corneal permeation study showed that the goat cornea absorbed 81% of MX cubogel than conventional formulations. From the results of antibacterial and histopathological studies, the selected formulations were safe for ocular administration. This study concluded that MX cubogel may be a suitable alternative to conventional eye drops due to its increased permeability and sustained release characteristics.
Keywords: Conjunctivitis, Cubosome, Glycerol monooleate, Moxifloxacin hydrochloride Poloxamer 407
Keywords:
Conjunctivitis, Cubosome, Glycerol monooleate, Moxifloxacin hydrochloride, oloxamer 407DOI
https://doi.org/10.22270/jddt.v14i3.6464References
Addo E, Bamiro O A, Siwale R. Ocular drug delivery advances, challenges and applications anatomy of the eye and common diseases affecting the eye. Drug deliv. 2016; 11-25. https://doi.org/10.1007/978-3-319-47691-9_2
Yumei W, Yuanyuan L, Xinyue L, Dereje K, Bing Z, Jing R et al. Research Progress of In-situ Gelling Ophthalmic Drug Delivery System. AJPS. 2018;14:1-15.
Ameeduzzafar Z, Omar A A, Syed S I,Mohammed Y, Khalid S A, Mohammad K. Formulation and evaluation of moxifloxacin loaded bilosomes in-situ gel- optimization to antibacterial evaluation. Gels. 2022; 8(418):1-21. https://doi.org/10.3390/gels8070418 PMid:35877503 PMCid:PMC9323078
Snehal S C, Jameel A S, Mulla A. Novel corticosteroids cubosomes for ocular drug delivery, IAJPR. 2020;10(6):775-784.
Khaled M H, Waleed Y R , Hala M A, Walaa A A, Rana B, Alshaimaa M A. et al., Nanocubosomal based Insitu Gel Loaded with Natamycin for Ocular Fungal Diseases: Development, Optimization, In-vitro and In-vivo Assessment. Drug Deliv. 2021; 28(1):1836-1848. https://doi.org/10.1080/10717544.2021.1965675 PMid:34515597 PMCid:PMC8439233
Tekade A R, Avhad G D. A review on cubosome a novel approach for drug delivery. IJPSR. 2022;13(2):579-588.
Tiantian Y,Kun Y, Wenji Z, Shuangshuang S,Fen C , Xinggang Y.et al., Prodrugs Incorporated into Nanotechnology based Drug Delivery Systems for Possible Improvement in Bioavailability of Ocular Drugs Delivery. AJPS. 2013; 8(4): 503-514. https://doi.org/10.1016/j.ajps.2013.09.002
Ankit A, Prakash G, Vedamurthy J. Development and characterization of prolonged release timolol maleate cubosomal gel for ocular drug delivery. APJ. 2019; 4(1):1-14. https://doi.org/10.31024/apj.2019.4.1.1
Hundekar Y R, Saboji J K, Patil S M, Nanjwade B K. Preparation and evaluation of diclofenac sodium cubosomes for percutaneous administration. WJPPS. 2014; 3(1): 523-539.
Karthika V T, Sheri P S, Kuriachan M A. Fabrication and evaluation of ketoprofen loaded cubogel for topical sustained delivery. IJRR .2018; 5(8): 149-159
Ankit A, Prakash G, Renukaradhya C, Basavaraj M D. Preparation of gellan gum and chitosan based in-situ gel of timolol maleate for ophthalmic drug delivery and evaluation of physicochemical properties and drug release profile.Acta.Sci.Pharm.Sci.2019; 3(2): 68-78.
Samia M O, Aliaa I, Kariman D H, Sara H D. Formulation and evaluation of cubosomes as skin retentive system for topical delivery of clotrimazole. Jour.Adv.Pharm.Res .2019; 3 (2) : 68-82. https://doi.org/10.21608/aprh.2019.9839.1079
Hoda E T, Islam A K, Heba M S. Novel cubosome based system for ocular delivery of acetazolamide. Drug Deliv. 2021;28(1): 2177-2186. https://doi.org/10.1080/10717544.2021.1989090 PMid:34662264 PMCid:PMC8528410
Anuja T K, Rahul L J, Pradnya B S, Satwashila S K. Design and evaluation of modified chitosan based insitu gel for ocular drug delivery. IJPPS. 2017; 9(11): 87-91. https://doi.org/10.22159/ijpps.2017v9i11.20938
Ananda K C, Madhubabu A, Padmanabha R A, Vasudha B, Vinod K Y. Design formulation in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel. Biointer. Res. in App. Che.2021; 11(4): 12037-12054. https://doi.org/10.33263/BRIAC114.1203712054
Sinar S, Mostafa A M, Mohamed M A, Omnia M K. Cubogel as potential platform for glaucoma management. Drug Deliv. 2021; 28 (1): 293-305. https://doi.org/10.1080/10717544.2021.1872740 PMid:33509004 PMCid:PMC7850357
Sachin K P, Atul K, Sandip B, Shitalkumar P. Formulation and evaluation of an insitu gel for ocular drug delivery of anticonjunctival drug. Cellu. Chem. Technol. 2015; 49(1): 35-40.
Ashwini S M, Ajay D S. Study of intraocular permeability enhancement of brimonidine tartrate by formulation in its in situ thermoreversible Gel. AJ P. 2016 ;10 (4): S527-S544.
Shun H, Jinqiu S, Yong G, Haiming G, Xinxin Z, Chunliu Z. et al., Novel Vehicle Based on Cubosomes for Ophthalmic Delivery of Flurbiprofen with Low Irritancy and High Bioavailability Acta Pharm. Sini. 2010; 31: 990-998. https://doi.org/10.1038/aps.2010.98 PMid:20686524 PMCid:PMC4007820
Zubair A, Pramod K S, Musarrat H W. Fabrication and evaluation of ketorolac loaded cubosome for ocular drug delivery. JAPS .2016; 6 (09): 204-208. https://doi.org/10.7324/JAPS.2016.60930
Harpreet K, Sharnjeet L, Rajeev G. Formulation and evaluation of in-situ ocular gel of gatifloxacin. Int. J. Pharma. Res. Health Sci. 2016; 4 (5): 1365-1370. https://doi.org/10.21276/ijprhs.2016.05.05
Published
Abstract Display: 647 
PDF Downloads: 1105 PDF Downloads: 78 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.